Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone
Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone
Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone
Submitted by
admin
on April 30, 2011 - 10:08am
Source:
Yahoo/PR NewsWire
News Tags:
Androgel
testosterone
Abbott Laboratories
Headline:
Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone
Do Not Allow Advertisers to Use My Personal information
